Patient safety and reduction of risk of transmission of Creutzfeldt-Jakob disease (CJD) via interventional procedures (NICE) November 2006

These recommendations for changes in practice needed to be both practical and achievable within a short time frame due to the fact that effective method for removing CJD infectivity from instruments is likely to be available and widely introduced within 5 years. The guidance has taken this into account. The recommendations also take into account the problems with availability and quality of single use instruments and imperfections in instrument tracking systems. The guidance includes recommendations on high-risk surgical procedures (intradural operations on the brain and operations on the retina or optic nerve and neuroendoscopy) A full list of high-risk procedures is given in Appendix C. The background to the recommendations is discussed in some detail as is the evidence and its interpretation. NICE has developed tools to help organisations implement this guidance and links to a quick reference guide, costing report, final report, systematic review and the project development and consultation documents can be found at www.nice.org.uk/IPG196 Recommendations for further research are included and the guidance will be reviewed in November 2008 or earlier if new and relevant evidence becomes available. Patient safety and reduction of risk of transmission of Creutzfeldt - Jakob disease (CJD) via interventional procedures: Slide Set was added 09/04/2008 http://www.nice.org.uk/Guidance/IPG196/SlideSet/ppt/English